SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma informs about outcome of board meeting

08 Feb 2024 Evaluate
Orchid Pharma has informed that pursuant to Regulation 30 read Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) and in reference to the Intimation given on February 02, 2024 of Board Meeting, the Board of Directors of the Company at its meeting held today i.e. February 08, 2024 (commenced at 01.00 pm and concluded at 03.35 pm) has considered and approved the Un-Audited Standalone & Consolidated Financial Result of the Company for quarter ended on December 31, 2023. Copy of Un-Audited Standalone & Consolidated Financial Result along with Limited Review Reports issued by Singhi & Co., a Chartered Accountant Firm, Statutory Auditors of the Company, are enclosed. Further, pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023 statement of utilisation and deviation or variation for quarter ended on December 31, 2023 is annexed. These are also being made available on the official website of the Company i.e. http://www.orchidpharma.com/

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma Share Price

544.95 -14.25 (-2.55%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×